Focus and Scope

Aims and Scope

IJDDPI publishes scientifically rigorous research that contributes to advances in pharmaceutical sciences and healthcare innovation. Areas of interest include, but are not limited to:

• Drug Discovery and Lead Optimization
• Medicinal and Pharmaceutical Chemistry
• Pharmaceutics and Pharmaceutical Technology
• Nanomedicine and Nanotechnology
• Novel Drug Delivery Systems
• Biopharmaceutics and Pharmacokinetics
• Pharmacology and Toxicology
• Pharmaceutical Analysis and Quality Assurance
• Pharmacognosy and Natural Products
• Pharmaceutical Biotechnology
• Clinical Pharmacy and Translational Medicine
• Pharmaceutical Microbiology
• Biomaterials and Tissue Engineering
• Artificial Intelligence and Computational Drug Discovery
• Precision Medicine
• Regulatory Affairs and Pharmaceutical Policy
• Industrial Pharmacy and Manufacturing Sciences

Manuscript Requirements

Manuscripts should present original, scientifically sound, and ethically conducted research. Studies describing novel chemical entities should include appropriate physicochemical and structural characterization using accepted analytical techniques, together with sufficient biological evaluation to support the proposed therapeutic relevance or mechanism of action.

Studies involving natural products should include adequate phytochemical characterization and experimental evidence supporting biological activity or mechanism of action. Computational studies, including molecular docking, molecular dynamics, machine learning, and artificial intelligence-based approaches, are encouraged when supported by meaningful experimental validation. The journal particularly welcomes innovative studies involving advanced pharmaceutical technologies, nanotechnology, biomaterials, pharmaceutical engineering, pharmacokinetic modelling, formulation optimization, and translational pharmaceutical research.

Article Types

• Original Research Articles
• Review Articles
• Systematic Reviews and Meta-Analyses
• Short Communications
• Technical Notes
• Perspectives and Commentaries
• Letters to the Editor